Atsumasa Komori
Omura, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
On-Treatment Reassessment of Type IV Collagen 7S and M2BPGi-Qt Improves Long-Term Hepatocellular Carcinoma Risk Stratification in Chronic Hepatitis B.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 24, 2026
Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRT.
Complementary Prognostic Value of ALBI Grade and Child-Pugh Classification in HCC Treated With SBRT.
Journal: Anticancer research
Published: May 06, 2026
Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 03, 2026
Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow-Up.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: March 04, 2026
Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2).
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C.
Journal: Hepatology international
Published: November 30, 2025
rs57494551 increases CXCR5 expression and IgM+ CXCR5+ B-cell infiltration in the portal area of primary biliary cholangitis.
Journal: Journal of gastroenterology
Published: October 02, 2025
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.
Journal: Hepatology international
Published: September 06, 2025
Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial.
Journal: Hepatology communications
Published: June 10, 2025
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Hepatology international
Published: April 30, 2025
Clinical Characteristics and Long-Term Prognosis of Primary Biliary Cholangitis in Japan: Results of the 2nd-Generation Nationwide Survey.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 26, 2025
Validation of PBC-10 in Japanese patients with primary biliary cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 19, 2025
Last Updated: 09/26/2026